Gastrointestinal stromal tumors (GISTs) have long been problematic in terms of classification and determination of prognosis. Recent studies have suggested that GISTs differentiate toward a phenotype resembling the interstitial cells of Cajal. This has led to the important discovery that activating mutations in the KIT receptor tyrosine kiase play an important role in the pathogenesis of GISTs. These findings have helped clarify the distinction between GISTs and other mesenchymal neoplasms of the gasrointestinal tract and may translate into an improved ability to predict biologic behavior, as well as suggesting possible avenues for rational drug design for the treatment of GISTs.
1. Golden T, Stout AP. Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues. Surg Gynecol Obstet73:784-810, 1941
2.
2. Martin JF, Bazin P, Feroldi J, Cabanne F. Tumeurs myoides intra-murales de 1'estomac-considerations microscopiques a propos de 6 cas. Ann Anat Pathol5:484-497, 1960
3.
3. Stout AP. Bizarre smooth muscle tumors of the stomach. Cancer15:400-409, 1962
4.
4. de Saint Aubain Somerhausen N, Fletcher CDM. Gastrointestinal stromal tumors: An update. Sarcoma2:133-141, 1998
5.
5. Herrera GA, Pinto de Moraes H, Grizzle WE, Han SG. Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm. Dig Dis Sci29:275-284, 1984
10. Mikhael Al, Bacchi CE, Zarbo RJ, Ma CK, Gown AM. CD34 expression in stromal tumors of the gastrointestinal tract. Appl Immunohistochem2:89-93, 1994
11.
11. Perez-Atayde AR, Shamberger RC, Kozakewich HW. Neuroectodermal differentiation of the gastrointestinal tumors in the Carney triad. An ultrastructural and immunohistochemical study. Am J Surg Pathol17:706-714, 1993
12.
12. Ramon y Cajal S. Sur les ganglions et plexus nerveux de l'intestin. Comp Rend Soc Biol Paris45:217-223, 1893
13.
13. Thuneberg L. Interstitial cells of Cajal. In Wood JD (ed.), Handbook of physiology-the gastrointestinal system. American Physiological Society, Bethesda, MD, pp. 349-386, 1989
14.
14. Kluppel M, Huizinga JD, Malysz J, Bernstein A. Developmental origin and KIT-dependent development of the interstitial cells of Cajal in the mammalian small intestine. Dev Dyn211:60-71, 1998
15.
15. Sanders KM. A case of interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology111:492-515, 1996
16.
16. Kindblom LG, Remotti HE, Aldenborg F, Meis-Kind-blom JM. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol152:1259-1269, 1998
17.
17. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Ann Rev Biochem57:443-448, 1988
18.
18. Martin FH, Suggs SV, Langley KE, Lu HS, Ting J, Okino KH, Morris CF, McNiece IK, Jacobsen FW, Mendiaz EA, Birkett NC, Smith KA, Johnson MJ, Parker VP, Flores JC, Patel AC, Fisher EF, Erjavec HO, Herrera CJ, Wypych J, Sachdev RK, Pope JA, Leslie I, Wen D, Lin C-H, Cuppies RL, Zsebo KM. Primary structure and functional expression of rat and human stem cell factor DNAs. Cell63:203-211, 1990
19.
19. Huang E, Nocka K, Beier DR, Chu T-Y, Buck J, Lahm H-W, Wellner D, Leder P, Besmer P. The hematopoietic growth factor KL is encoded by the S/ locus and is the ligand of the c-kit receptor, the gene product of the Wlocus. Cell63:225-233, 1990
20.
20. Russell ES. Hereditary anemia of the mouse: A review for geneticists. Adv Gen20:357-459, 1979
21.
21. Kitamura Y, Go S, Hatanaka K. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood52:447-452, 1978
22.
22. Kitamura Y, Go S. Decreased production of mast cells in S I /S I d anemic mice. Blood53:492-497, 1979
23.
23. Maeda H, Yamagata A, Nishikawa S, Yoshinaga K, K(obayashi S, Nishi K, Nishikawa S. Requirement of c-kit for development of intestinal pacemaker system. Development116:369-375, 1992
24.
24. Isozaki K, Hirota S, Nakama A, Miyagawa J, Shinomura Y, Xu Z, Nomura S, Kitamura Y. Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats. Gastroenterology109:456-464, 1995
25.
25. Huizinga JD, Thuneberg L, Kluppel M, Malysz J, Mikkelsen HB, Bernstein A. Wikit gene required for interstitial cells of Cajal and for intestinal pacemaker activity. Nature373:347-349, 1999
26.
26. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest92:1736-1744, 1993
27.
27. Tsujimura T, Furitsu T, Morimoto M, Isozaki K, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood83:2619-2626, 1994
28.
28. Tsujimura T, Furitsu T, Morimoto M, Kanayama Y, Nomura S, Matsuzawa Y, Kitamura Y, Kanakura Y. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol106:377-385, 1995
29.
29. Tsujimura T, Morimoto M, Hashimoto K, Moriyama Y, Kitayama H, Matsuzawa Y, Kitamura Y, Kanakura Y. Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain. Blood87:273-283, 1996
30.
30. Nagata H, Worobec AS, Oh CK, Chowdhury BA, Tannenbaum S, Suzuki Y, Metcalfe DD. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA92:10560-10564, 1995
31.
31. Longley BJ, Tyrrell L, Lu SZ, Ma YS, Langley K, Ding TG, Duffy T, Jacobs P, Tang LH, Modlin I. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm. Nat Genet12:312-314, 1996
32.
32. Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, Muhammad Tunio G, Matsuzawa Y, Kanakura Y, Shinomura Y, Kitamura Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science279:577-580, 1998
33.
33. Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, Kitamura Y. Familial gastrointestinal stromal tumors with germline mutation of the KIT gene. Nat Genet19:323-324, 1998
34.
34. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD 117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol11:728-734, 1998
35.
35. Sircar K, Hewlett BR, Huizinga JD, Chorneyko K, Berezio I, Riddell RH. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol23:377-389, 1999
36.
36. Sakurai S, Fukasawa T, Chong J-M, Tanaka A, Fukayama M. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal. Am J Pathol154:23-28, 1999
37.
37. Boghosian L, Dal Cin P, Turc-Carel C, Rao U, Karakousis C, Sait SJ, Sandberg AA. Three possible cytogenetic subgroups of leiomyosarcoma. Cancer Genet Cytogenet43:39-49, 1989
38.
38. Dal Cin P, Boghosian L, Sandberg AA. Cytogenetic findings in leiomyosarcoma of the small bowel. Cancer Genet Cytogenet30:285-288, 1988
39.
39. Marci V, Casorzo L, Sarotto I, Dogliani N, Milazzo MG, Risio M. Gastrointestinal stromal tumor, uncommitted type, with monosomies 14 and 22 as the only chromosomal abnormalities. Cancer Genet Cytogenet102:135-138, 1998
40.
40. Mark J, Wedell B, Dahlenfors R, Havel G. Cytogenetic observations in a human gastric leiomyosarcoma. Cancer Genet Cytogenet37:215-220, 1989
41.
41. el-Rifai W, Sarlomo-Rikala M, Miettinen M, Knuutila S, Andersson LC. DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors. Cancer Res56:3230-3233, 1996
42.
42. Emory TS, O'Leary TJ. Prognosis and surveillance of gastrointestinal stromal/smooth muscle tumors. Ann Chir Gynaecol87:306-310, 1998
43.
43. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res59:4297-4300, 1999
44.
44. Moskaluk CA, Tian Q, Marchall CR, Rumpel CA, Franquemont DW, Frierson HF. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors. Oncogene18:1897-1902, 1999
45.
45. Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M. Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol154:53-60, 1999
46.
46. Ernst SI, Hubbs AE, Przygodzki RM, Emory TS, Sobin LH, O'Leary TJ. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest78:1633-1636, 1998
47.
47. Kindblom LG, Remotti HE, Angervall L, Meid-Kindblom L. Gastrointestinal pacemaker cell tumor-a manifestation of neurofibromatosis type I (NFI). Mod Pathol, 12:77A-77A, 1999
